ANG Lifesciences India Share Price
36.50+0.56 (+1.56%)
+18.70% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
Share Price Live Stats
No results found
Share Market Cap & Key Ratios Overview
No results found
About
No results found
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
No results found
ANG Lifesciences India Share Price
36.50+0.56 (+1.56%)
+18.70% past 1 Year
Financial overview
Peer Comparison
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Balance Sheet
Consolidated
Standalone
₹
%
Cash Flow
Consolidated
Standalone
₹
%
Fundamental Ratios
Consolidated
Standalone
ANG Lifesciences India Share Price
36.50+0.56 (+1.56%)
+18.70% past 1 Year
Technical meters
No results found
Pivot
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
ANG Lifesciences India Share Price
36.50+0.56 (+1.56%)
+18.70% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
No results found
Bulk & block deals
No results found
Insider trading & SAST
No results found
ANG Lifesciences India Share Price
36.50+0.56 (+1.56%)
+18.70% past 1 Year
Corporate Actions
Date
Type
Details
Company details
ANG Lifesciences India Share Price
36.50+0.56 (+1.56%)
+18.70% past 1 Year
Corporate filings & documents
No corporate filings & documents found
ANG Lifesciences India Share Price
36.50+0.56 (+1.56%)
+18.70% past 1 Year
News
SMS Pharmaceuticals Reports Strong Second Quarter Revenue And Profit Growth
Equity
SMSPHARMA
Arman Financial Services Reports Strong Second Quarter Revenue Growth
Equity
ARMANFIN
Arman Financial Services Reports Sharp Year On Year Profit Growth
Equity
ARMANFIN
NDR Auto Components Reports Higher Q2 EBITDA Despite Margin Compression
Equity
NDRAUTO
NDR Auto Components Reports Stronger Second Quarter Revenue And Profit
Equity
NDRAUTO
Exide Industries Reports Stronger Second Quarter EBITDA And Margin
Equity
EXIDEIND
Biocon Reports Q2 Revenue Growth To Rs 4400 Crores
Equity
BIOCON
Exide Industries Reports Strong Second Quarter Revenue Growth
Equity
EXIDEIND
Exide Industries Reports Strong Year On Year Net Profit Growth
Equity
EXIDEIND
NSE Reports Rs 275.33 Crores BSE Block Trade At Rs 1809.95
Equity
NSE
Biocon Q2 Consolidated Net Profit Falls Below Estimates
Equity
BIOCON
Biocon Q2 EBITDA Declines Marginally, Margin Contracts Year On Year
Equity
BIOCON
HMVL Reports Stronger Q2 EBITDA And Improved Operating Margin
Equity
HMVL
HMVL Reports Strong Q2 Consolidated Net Profit Growth Year On Year
Equity
HMVL
V2 Retail Lowers Same Store Sales Growth Guidance For Current Financial Year
Equity
V2RETAIL
Rustomjee Q2 Revenue Flat While Consolidated PBT More Than Doubles
Equity
RUSTOMJEE
Rustomjee Q2 EBITDA rises sharply with substantial margin expansion
Equity
RUSTOMJEE
Sunclay Q2 EBITDA More Than Doubles As Margin Expands Year On Year
Equity
SUNCLAY
Sunclay Reports Higher Revenue And Narrower Consolidated Net Loss In Q2
Equity
SUNCLAY
Steel Exchange India Reports Higher Q2 EBITDA Despite Margin Compression
Equity
STEELXIND